Sex Differences in the Evolution of Neutralizing Antibodies to Severe Acute Respiratory Syndrome Coronavirus 2
Authors:
Open Access
- 7 March 2021
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 224 (6) , 983-988
Abstract
We measured anti-spike (S), nucleoprotein (N), and neutralizing antibodies in sera from 308 healthcare workers with a positive reverse-transcription quantitative polymerase chain reaction result for severe acute respiratory syndrome coronavirus 2 and with mild disease, collected at 2 timepoints up to 6 months after symptom onset. At month 1, anti-S and -N antibody levels were higher in male participants aged >50 years and participants with a body mass index (BMI) >25 kg/m2. At months 3–6, anti-S and anti-N antibodies were detected in 99% and 59% of individuals, respectively. Anti-S antibodies and neutralizing antibodies declined faster in men than in women, independent of age and BMI, suggesting an association of sex with evolution of the humoral response.Keywords
All Related Versions
Funding Information
- SeroCoV-HUS (PRI 7782)
- Agence Nationale de la Recherche (ANR-18-CE17-0028)
- Laboratoire d’Excellence (ANR-11-LABX-0070_TRANSPLANTEX)
- Institut National de la Santé et de la Recherche Médicale (UMR_S 1109)
- Institut Pasteur, Urgence COVID-19 Fundraising Campaign of Institut Pasteur, ANRS, Sidaction
- Vaccine Research Institute (ANR-10-LABX-77)
- LABEX IBEID (ANR-10-LABX-62-IBEID)
- TIMTAMDEN (ANR-14-CE14-0029)
- CHIKV-Viro-Immuno (ANR-14-CE14-0015-01)
This publication has 15 references indexed in Scilit:
- Robust neutralizing antibodies to SARS-CoV-2 infection persist for monthsScience, 2020
- Quick COVID-19 Healers Sustain Anti-SARS-CoV-2 Antibody ProductionCell, 2020
- Evaluation of the performance of SARS-CoV-2 serological tools and their positioning in COVID-19 diagnostic strategiesDiagnostic Microbiology and Infectious Disease, 2020
- Loss of Anti–SARS-CoV-2 Antibodies in Mild Covid-19New England Journal of Medicine, 2020
- Persistence of serum and saliva antibody responses to SARS-CoV-2 spike antigens in COVID-19 patientsScience Immunology, 2020
- Persistence and decay of human antibody responses to the receptor binding domain of SARS-CoV-2 spike protein in COVID-19 patientsScience Immunology, 2020
- Rapid Decay of Anti–SARS-CoV-2 Antibodies in Persons with Mild Covid-19New England Journal of Medicine, 2020
- A comparison of four serological assays for detecting anti–SARS-CoV-2 antibodies in human serum samples from different populationsScience Translational Medicine, 2020
- Serologic responses to SARS-CoV-2 infection among hospital staff with mild disease in eastern FranceEBioMedicine, 2020
- Clinical and immunological assessment of asymptomatic SARS-CoV-2 infectionsNature Medicine, 2020